Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Incereb was an Irish neonatal neurodiagnostics medical device company focused on disposable EEG and cerebral function monitoring products for term and preterm infants in neonatal intensive care settings. Its core product line, marketed under the NEON brand, was designed to enable rapid, low-training setup of neonatal brain monitoring and to interface with multiple EEG and aEEG systems. The company collaborated with Irish hospitals and universities to translate neonatal neurology research into commercial products. Incereb was founded in 2011 in Dublin and was acquired by Lifelines Neurodiagnostic Systems in October 2018. Following the acquisition, the Incereb brand and NEON products have continued to appear in commercial channels, but Incereb itself is best characterized as an acquired company rather than an independent operating biotech or pharma business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Incereb.